Overcoming the Anatomical and Physiological Barriers in Topical Eye Surface Medication Using a Peptide-Decorated Polymeric Micelle

ACS Appl Mater Interfaces. 2019 Oct 30;11(43):39603-39612. doi: 10.1021/acsami.9b13851. Epub 2019 Oct 16.

Abstract

The sealed anatomical features of the eye and its physiological activity that rapidly removes drugs are called anatomical and physiological barriers, which are the cause of more than 90% of drug loss. This aspect remains a critical issue in eye surface medication. Thus, promoting tissue permeability of drugs as well as prolonging their retention on the eye surface can improve their bioavailability and enhance their therapeutic effects. Thanks to the existence of a negatively charged mucin layer on the eye surface, several peptide-decorated polymeric micelles were prepared to enhance the interaction between the micelle and eye surface, thus prolonging the drug retention on the eye surface and promoting its tissue permeability. Tacrolimus (also known as FK506) is a hydrophobic macrolide immunosuppressant used to treat dry eye syndrome and other eye diseases. However, its hydrophobic nature makes its delivery as a topical eye surface medication difficult, with the risk of side effects due to overdoses. Therefore, the aim of this work is to evaluate the ability of FK506 micelles in promoting their permeability on the eye surface. Our results showed that the positively charged nanomicelles could significantly prolong FK506 retention on the eye surface and enhance its corneal permeability in ex vivo and in vivo conditions. FK506 nanomicelles exhibited superior curing effects against dry eye diseases than the FK506 suspension and a commercial FK506 formula. It exerted better inhibitory effects on eye surface inflammation and corneal epithelium apoptosis when examined by a slip lamp and a transferase-mediated dUTP nick end labeling assay, respectively. Further assays revealed the higher suppressive effects on the expression of several inflammation-related factors at an mRNA and protein level. Hence, our results suggested that these positively charged nanomicelles might be a good drug delivery system for ocular surface medication.

Keywords: anatomical and physiological barriers; corneal permeation; eye surface medication; eye surface retention; peptide-decorated polymeric micelle.

MeSH terms

  • Administration, Topical
  • Animals
  • Cornea / metabolism*
  • Cornea / pathology
  • Dry Eye Syndromes* / drug therapy
  • Dry Eye Syndromes* / metabolism
  • Dry Eye Syndromes* / pathology
  • Micelles*
  • Ophthalmic Solutions* / chemistry
  • Ophthalmic Solutions* / pharmacokinetics
  • Ophthalmic Solutions* / pharmacology
  • Peptides* / chemistry
  • Peptides* / pharmacokinetics
  • Peptides* / pharmacology
  • Permeability
  • Rabbits
  • Tacrolimus* / chemistry
  • Tacrolimus* / pharmacokinetics
  • Tacrolimus* / pharmacology

Substances

  • Micelles
  • Ophthalmic Solutions
  • Peptides
  • Tacrolimus